3,4-dihydroxyphenylacetaldehyde has been researched along with benomyl in 2 studies
Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (benomyl) | Trials (benomyl) | Recent Studies (post-2010) (benomyl) |
---|---|---|---|---|---|
99 | 0 | 50 | 529 | 1 | 64 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnhill, L; Bronstein, JM; Casida, JE; Cockburn, M; Fitzmaurice, AG; Lam, HA; Lulla, A; Maidment, NT; Murphy, NP; O'Donnell, KC; Rhodes, SL; Ritz, B; Sagasti, A; Stahl, MC | 1 |
Casida, JE; Cooney, A; Ford, B; Goldstein, DS; Jinsmaa, Y; Sullivan, P | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and benomyl
Article | Year |
---|---|
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Benomyl; Dopaminergic Neurons; Flow Cytometry; Fungicides, Industrial; Humans; Logistic Models; Mesencephalon; Mitochondria; Nerve Degeneration; Odds Ratio; Parkinson Disease; Rats; Zebrafish | 2013 |
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Aldehydes; Animals; Antifungal Agents; Benomyl; Cell Line; Enzyme Inhibitors; Humans; Lipid Peroxidation; Mice; Parkinson Disease; PC12 Cells; Rats | 2014 |